Paediatric viral myocarditis successfully treated with interferon beta-1b and corticoids

Area of Science:

• Pediatric Cardiology
• Virology
• Immunology

Background:

• Viral myocarditis in infants is rare with limited treatment data.
• Existing evidence for interferon beta-1B is restricted to children over two years old.

Observation:

• Two infants under one year presented with respiratory symptoms and myocardial damage.
• Parvovirus-B19 was identified as the causative agent via PCR.
• Interferon beta-1B treatment was administered to both infants.

Findings:

• Complete cardiac function recovery was observed in both infants six months post-treatment.
• The study demonstrates the potential efficacy of interferon beta-1B in treating infant viral myocarditis.

Implications:

• This is the first case series detailing interferon beta-1B use in infants with viral myocarditis.
• Findings suggest interferon beta-1B as a viable therapeutic option for this vulnerable population.
• Further research is warranted to confirm safety and efficacy in larger infant cohorts.